Sycal Ventures Berhad (KLSE:SYCAL)

Intra-Cellular Therapies Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Dec 31, 2020
Cash & Equivalents	4.94	-	-	4.56	1.84	5.53
Short-Term Investments	3.31	5.46	5.38	3.29	3.54	2.63
Cash & Short-Term Investments	8.24	5.46	5.38	7.84	5.39	8.15
Cash Growth	32.67%	1.41%	-31.42%	45.66%	-33.96%	-
Accounts Receivable	160.59	186.38	138.76	138.4	140.53	115.16
Other Receivables	44.42	70.3	58.42	42.61	42.67	56.34
Receivables	205.02	256.67	197.18	181.01	183.2	171.5
Inventory	171.13	156.83	172.59	174.53	181.31	100.1
Prepaid Expenses	0.02	0.02	0.08	0.06	2.75	3.21
Other Current Assets	4.98	4.98	3.99	7.37	7.15	-
Total Current Assets	389.39	423.95	379.22	370.81	379.79	282.97
Property, Plant & Equipment	19.86	1.2	25.17	28.78	31.72	54.35
Long-Term Deferred Tax Assets	3.19	3.19	4.12	4.71	4.55	4.7
Other Long-Term Assets	58.66	58.68	58.69	58.68	57.24	160.97
Total Assets	471.1	487.02	467.19	462.97	473.29	502.98
Accounts Payable	33.98	41.07	42.36	41.1	55.68	35.08
Accrued Expenses	-	2.96	2.5	2.73	3	24.25
Short-Term Debt	9.62	4.53	4.53	4.52	1.52	1.53
Current Portion of Long-Term Debt	1.67	1.52	8.97	11.81	0.3	3.56
Current Portion of Leases	0.03	0.12	2.06	2.03	2.26	2.48
Current Income Taxes Payable	19.17	19.35	21.3	21.55	20.3	17.61
Current Unearned Revenue	49.24	53.6	25.24	45.44	37.11	46.29
Other Current Liabilities	43.73	47.82	48.63	17.33	34.23	39.48
Total Current Liabilities	157.44	170.96	155.6	146.5	154.41	170.27
Long-Term Debt	24.89	26.68	23.18	26.69	28.17	39.25
Long-Term Leases	-	-	2.57	4.62	6.18	7.39
Long-Term Deferred Tax Liabilities	0.22	1.37	0.23	0.6	0.65	0.91
Other Long-Term Liabilities	3.35	2.97	3.35	3.35	3.35	3.35
Total Liabilities	185.91	201.98	184.93	181.76	192.75	221.17
Common Stock	120.76	120.76	120.76	120.76	120.76	120.76
Retained Earnings	128.3	128.25	126.34	124.7	123.43	124.2
Comprehensive Income & Other	32.67	32.67	32.79	33.26	33.64	33.76
Total Common Equity	281.73	281.68	279.9	278.72	277.83	278.73
Minority Interest	3.47	3.36	2.36	2.5	2.71	3.08
Shareholders' Equity	285.2	285.04	282.26	281.22	280.54	281.81
Total Liabilities & Equity	471.1	487.02	467.19	462.97	473.29	502.98
Total Debt	36.21	32.84	41.32	49.67	38.44	54.2
Net Cash (Debt)	-27.97	-27.39	-35.94	-41.83	-33.05	-46.05
Net Cash Per Share	-0.07	-0.07	-0.09	-0.10	-0.08	-0.11
Filing Date Shares Outstanding	416.32	416.32	416.32	416.32	416.32	416.32
Total Common Shares Outstanding	416.32	416.32	416.32	416.32	416.32	416.32
Working Capital	231.95	252.99	223.62	224.31	225.38	112.7
Book Value Per Share	0.68	0.68	0.67	0.67	0.67	0.67
Tangible Book Value	281.73	281.68	279.9	278.72	277.83	278.73
Tangible Book Value Per Share	0.68	0.68	0.67	0.67	0.67	0.67
Land	-	1.26	1.26	1.26	1.26	-
Machinery	-	24.06	25.46	23.92	22.95	-
Construction In Progress	-	-	18.66	18.66	18.33	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.